Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Fujiwara

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
Therapeutic Advances in Medical Oncology|June 7, 2024
Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trialsSusu Zhou, Nobuyuki Horita, Theresa Shao, et al.
JNCI Cancer Spectrum|January 25, 2026
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysisReo Omori, Yu Fujiwara, Kota Tokunaga, et al.
Frontiers in Microbiology|June 14, 2021
Zoantharian Endosymbiont Community Dynamics During a Stress EventYu Fujiwara, Iori Kawamura, James Davis Reimer, et al.
Progress in Rehabilitation Medicine|April 18, 2022
Rehabilitation Characteristics of Acute-stage COVID-19 Survivors Managed with Extracorporeal Membrane Oxygenation in the Intensive Care UnitTomoko Sakai, Chisato Hoshino, Megumi Nakano, et al.
Cancer|August 18, 2021
Self-assessment of health status among lesbian, gay, and bisexual cancer survivors in the United StatesYannan Li, Nicholas Theodoropoulos, Yu Fujiwara, et al.
Cancer Treatment Reviews|October 6, 2024
Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysisRiona Aburaki, Yu Fujiwara, Kohei Chida, et al.
Seminars in Arthritis and Rheumatism|February 5, 2026
Flare incidences of pre-existing rheumatologic diseases in patients with solid tumors receiving immune checkpoint inhibitors: A systematic review and meta-analysisKenji Yamada, Takemichi Matsui, Toshiaki Takahashi, et al.
Journal of Immunotherapy and Precision Oncology|April 17, 2026
Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and BeyondSoon Khai Low, Yu Fujiwara, Daisuke Nishizaki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2022
Clinical Characteristics and Outcomes of Gastritis Associated With Immune Checkpoint Inhibitors: Scoping ReviewAdham Obeidat, Krixie Silangcruz, Landon Kozai, et al.
No to Hattatsu = Brain and Development|July 17, 2018
Combinatory use of central venous catheter and ethanol lock for a patient with X-linked lissencephaly with ambiguous genitalia (XLAG) syndromeHirotaka Motoi, Hiroyuki Shimizu, Yu Fujiwara, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
Therapeutic Advances in Medical Oncology|June 7, 2024
Endocrine adverse events in patients with cancer receiving perioperative immune checkpoint blockade: a meta-analysis of randomized controlled trialsSusu Zhou, Nobuyuki Horita, Theresa Shao, et al.
JNCI Cancer Spectrum|January 25, 2026
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysisReo Omori, Yu Fujiwara, Kota Tokunaga, et al.
Frontiers in Microbiology|June 14, 2021
Zoantharian Endosymbiont Community Dynamics During a Stress EventYu Fujiwara, Iori Kawamura, James Davis Reimer, et al.
Progress in Rehabilitation Medicine|April 18, 2022
Rehabilitation Characteristics of Acute-stage COVID-19 Survivors Managed with Extracorporeal Membrane Oxygenation in the Intensive Care UnitTomoko Sakai, Chisato Hoshino, Megumi Nakano, et al.
Cancer|August 18, 2021
Self-assessment of health status among lesbian, gay, and bisexual cancer survivors in the United StatesYannan Li, Nicholas Theodoropoulos, Yu Fujiwara, et al.
Cancer Treatment Reviews|October 6, 2024
Surgical and safety outcomes in patients with non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy versus chemotherapy alone: A systematic review and meta-analysisRiona Aburaki, Yu Fujiwara, Kohei Chida, et al.
Seminars in Arthritis and Rheumatism|February 5, 2026
Flare incidences of pre-existing rheumatologic diseases in patients with solid tumors receiving immune checkpoint inhibitors: A systematic review and meta-analysisKenji Yamada, Takemichi Matsui, Toshiaki Takahashi, et al.
Journal of Immunotherapy and Precision Oncology|April 17, 2026
Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and BeyondSoon Khai Low, Yu Fujiwara, Daisuke Nishizaki, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 16, 2022
Clinical Characteristics and Outcomes of Gastritis Associated With Immune Checkpoint Inhibitors: Scoping ReviewAdham Obeidat, Krixie Silangcruz, Landon Kozai, et al.
No to Hattatsu = Brain and Development|July 17, 2018
Combinatory use of central venous catheter and ethanol lock for a patient with X-linked lissencephaly with ambiguous genitalia (XLAG) syndromeHirotaka Motoi, Hiroyuki Shimizu, Yu Fujiwara, et al.
Pageof 7